Proteinase specificity and functional diversity in po plasminogen activator inhibitor 1

被引:43
作者
Gils, A [1 ]
Declerck, PJ [1 ]
机构
[1] CATHOLIC UNIV LEUVEN,FAC PHARMACEUT SCI,LAB PHARMACEUT BIOL & PHYTOPHARMACOL,B-3000 LOUVAIN,BELGIUM
关键词
D O I
10.1074/jbc.272.19.12662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) is a unique member of the serpin superfamily. The alternative behavior of PAI-1 as an inhibitor, a non-inhibitory substrate, or a non-reactive latent form has been shown to be dependent on the initial conformation. In this study, we have evaluated the effect of a substitution outside the reactive site loop (P18) or in the reactive site loop (P6 and P10) on proteinase specificity and conformational transitions in PAI-1. Wild-type PAI-1 (wtPAI-1) revealed the same conformational distribution pattern toward tissue-type plasminogen activator (t-PA) as toward urokinase-type plasminogen activator (u-PA) (i.e. 53 +/- 6.9% active, 36 +/- 6.8% latent, and 12 +/- 1.9% substrate). Inactivation of wtPAI-1 resulted in the conversion of the labile active form into the latent form while the stable substrate form remained unchanged. PAI-1-P6 (Val --> Pro at P6) revealed a target specificity for t-PA (39 +/- 7% versus 3 +/- 2% of the theoretical maximal value toward t-PA and u-PA, respectively), PAI-1-P10 (Ser --> Pro at P10) was 4-fold more active toward u-PA than toward t-PA, and PAI-1-P18 (Asn --> Pro at P18) exhibited inhibitory properties exclusively toward u-PA (41 +/- 10%). Surprisingly, inactivation of these mutants revealed functional and conformational transitions distinct from those observed for wtPAI-1. Inactivation of PAI-1-P6 (Val --> Pro) resulted in a total conversion of the active form into the latent form and in a partial conversion of the substrate form into the latent form, The active forms of both PAI-1-P10 (Ser --> Pro) and PAI-1-P18 (Asn --> Pro) are also labile but, in contrast to the active form of wtPAI-1, convert into substrate forms. Based on the existence of various conformations of PAI-1, we propose an alternative reaction scheme describing the putative interactions between serpins and their target proteinases. The unusual conformational and functional flexibility of PAI-1 that, according to the current study, appears not to be restricted to the reactive site loop further underlines the importance of potential structural rearrangements (e.g. upon binding to cofactors) in PAI-1 (or serpins in general) for its functional behavior at particular biological sites.
引用
收藏
页码:12662 / 12666
页数:5
相关论文
共 48 条
[31]   ENDOTHELIAL PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) - A NEW MEMBER OF THE SERPIN GENE FAMILY [J].
PANNEKOEK, H ;
VEERMAN, H ;
LAMBERS, H ;
DIERGAARDE, P ;
VERWEIJ, CL ;
VANZONNEVELD, AJ ;
VANMOURIK, JA .
EMBO JOURNAL, 1986, 5 (10) :2539-2544
[32]   MECHANISM OF SERPIN ACTION - EVIDENCE THAT C1 INHIBITOR FUNCTIONS AS A SUICIDE SUBSTRATE [J].
PATSTON, PA ;
GETTINS, P ;
BEECHEM, J ;
SCHAPIRA, M .
BIOCHEMISTRY, 1991, 30 (36) :8876-8882
[33]   SERPINS ARE SUICIDE SUBSTRATES - IMPLICATIONS FOR THE REGULATION OF PROTEOLYTIC PATHWAYS [J].
PATSTON, PA ;
GETTINS, PGW ;
SCHAPIRA, M .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1994, 20 (04) :410-416
[34]  
PATSTON PA, 1990, J BIOL CHEM, V265, P10786
[35]  
PERRY DJ, 1989, MOL BIOL MED, V6, P239
[36]  
PHILLIPS JE, 1994, J BIOL CHEM, V269, P16696
[37]  
RUBIN H, 1990, J BIOL CHEM, V265, P1199
[38]  
SCHECHTER NM, 1993, J BIOL CHEM, V268, P23626
[39]  
SHERMAN PM, 1992, J BIOL CHEM, V267, P7588
[40]   IDENTIFICATION OF TISSUE-TYPE PLASMINOGEN ACTIVATOR-SPECIFIC PLASMINOGEN-ACTIVATOR INHIBITOR-1 MUTANTS - EVIDENCE THAT 2ND SITES OF INTERACTION CONTRIBUTE TO TARGET SPECIFICITY [J].
SHERMAN, PM ;
LAWRENCE, DA ;
VERHAMME, IM ;
PAIELLI, D ;
SHORE, JD ;
GINSBURG, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (16) :9301-9306